BioSpace News Archive

Business

BiocurePharm, Korea (BPK) Signs MOU With Symbasis GmbH to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL)

Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) (CURE or the Company) BiocurePharm, Korea (BPK), a subsidiary of Biocure Technology Inc. (CURE) is pleased to announce that BPK has entered into a MOU with Symbasis GmbH.

January 4, 2021
·
7 min read
Policy

Zosano Pharma Requests Type A Meeting with the FDA to Review Resubmission Plans for Qtrypta™ New Drug Application

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced that on December 30, 2020 the company requested a Type A meeting with the U.S. Food and Drug Administration.

January 4, 2021
·
3 min read
Deals

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 04, 2021

X4 Pharmaceuticals, Inc. announced that, on December 31, 2020, the Compensation Committee of X4’s Board of Directors issued an inducement award to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.

January 4, 2021
·
2 min read
Genetown

Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference

Editas Medicine, Inc., a leading genome editing company, announced that it will present a company overview at the 39th Annual J.P. Morgan Healthcare Conference, held virtually, on Wednesday, January 13, 2021, at 10:50 a.m. ET.

January 4, 2021
·
1 min read
BioForest

Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference

Neovasc Inc., announced its participation in the H.C. Wainwright BioConnect 2021 Virtual Conference, which takes place January 11-14, 2021.

January 4, 2021
·
1 min read
Pharm Country

Tiziana Life Sciences plc announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil

The scientific approaches underlying this clinical study could potentially be effective against SARs, MERS, and all variants of coronaviruses

January 4, 2021
·
5 min read
Pharm Country

Amarin to Present at 39th Annual J.P. Morgan Healthcare Conference

Amarin Corporation plc announced that John F. Thero, Amarin’s president and chief executive officer, is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 from 2:00 - 2:40 p.m. Eastern Time.

January 4, 2021
·
2 min read
Biotech Bay

IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced its participation at the following upcoming investor relations events and scientific conferences.

January 4, 2021
·
2 min read
Business

Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA™

Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced the appointment of Robert Cohen as Chief Executive Officer effective January 1, 2021.

January 4, 2021
·
5 min read
BioCapital

Emergent BioSolutions to Participate in Investor Conferences - Jan 04, 2021

Emergent BioSolutions Inc. announced that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2021

January 4, 2021
·
1 min read